Imaging of lung cancer resistance to EGFR tyrosine kinase inhibitors through Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type 3

被引：0
|
作者：
Zannetti, A. [1 ]
Iommelli, F. [1 ]
Fonti, R. [1 ]
Papaccioli, A. [1 ]
Sommella, J. [1 ]
Lettieri, A. [1 ]
Bianco, R. [2 ]
Tortora, G. [2 ]
Salvatore, M. [3 ]
Del Vecchio, S. [3 ]
机构：
[1] CNR, Inst Biostruct & Bioimages, Naples, Italy
[2] Univ Naples Federico II, Dept Endocrinol & Mol & Clin Oncol, Naples, Italy
[3] Univ Naples Federico II, Dept Biomorphol & Funct Sci, Naples, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2008年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S187 / S187
页数：1
相关论文
共 50 条
  • [41] Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells
    Okamoto, Koichi
    Zaanan, Aziz
    Kawakami, Hisato
    Huang, Shengbing
    Sinicrope, Frank A.
    MOLECULAR CANCER RESEARCH, 2015, 13 (04) : 659 - 669
  • [42] Combined inhibition of Bcl-2/Bcl-xL and Usp9X/Bag3 overcomes apoptotic resistance in glioblastoma in vitro and in vivo
    Karpel-Massler, Georg
    Shu, Chang
    Chau, Lily
    Banu, Matei
    Halatsch, Marc-Eric
    Westhoff, Mike-Andrew
    Ramirez, Yulian
    Ross, Alonzo H.
    Bruce, Jeffrey N.
    Canoll, Peter
    Siegelin, Markus D.
    ONCOTARGET, 2015, 6 (16) : 14507 - 14521
  • [43] Combined Targeting of JAK2 and Bcl-2/Bcl-xL to Cure Mutant JAK2-Driven Malignancies and Overcome Acquired Resistance to JAK2 Inhibitors
    Waibel, Michaela
    Solomon, Vanessa S.
    Knight, Deborah A.
    Ralli, Rachael A.
    Kim, Sang-Kyu
    Banks, Kellie-Marie
    Vidacs, Eva
    Virely, Clemence
    Sia, Keith C. S.
    Bracken, Lauryn S.
    Collins-Underwood, Racquel
    Drenberg, Christina
    Ramsey, Laura B.
    Meyer, Sara C.
    Takiguchi, Megumi
    Dickins, Ross A.
    Levine, Ross
    Ghysdael, Jacques
    Dawson, Mark A.
    Lock, Richard B.
    Mullighan, Charles G.
    Johnstone, Ricky W.
    CELL REPORTS, 2013, 5 (04): : 1047 - 1059
  • [44] Estrogen Receptor β Is Involved in Acquired Resistance to EGFR-tyrosine Kinase Inhibitors in Lung Cancer
    Sugiura, Hiroki
    Miki, Yasuhiro
    Iwabuchi, Erina
    Saito, Ryoko
    Ono, Katsuhiko
    Sato, Ikuro
    Okada, Yoshinori
    Sasano, Hironobu
    ANTICANCER RESEARCH, 2021, 41 (05) : 2371 - 2381
  • [45] Synchronised phosphorylation of BNIP3, Bcl-2 and Bcl-xL in response to microtubule-active drugs is JNK-independent and requires a mitotic kinase
    Mellor, Howard R.
    Rouschop, Kasper M.
    Wigfield, Simon M.
    Wouters, Bradly G.
    Harris, Adrian L.
    BIOCHEMICAL PHARMACOLOGY, 2010, 79 (11) : 1562 - 1572
  • [46] Finasteride induces apoptosis via Bcl-2, Bcl-xL, Bax and caspase-3 proteins in LNCaP human prostate cancer cell line
    Golbano, Jesus M.
    Lopez-Aparicio, Pilar
    Recio, Maria N.
    Perez-Albarsanz, Miguel A.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 32 (04) : 919 - 924
  • [47] Protease-activated receptor 2 stabilizes Bcl-xL and regulates EGFR-targeted therapy response in colorectal cancer
    Li, Weiwei
    Ma, Yiming
    He, Longmei
    Li, Hongwei
    Chu, Yi
    Jiang, Zheng
    Zhao, Xinhua
    Nie, Yongzhan
    Wang, Xishan
    Wang, Hongying
    CANCER LETTERS, 2021, 517 : 14 - 23
  • [48] Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl
    Monaco, G.
    Decrock, E.
    Akl, H.
    Ponsaerts, R.
    Vervliet, T.
    Luyten, T.
    De Maeyer, M.
    Missiaen, L.
    Distelhorst, C. W.
    De Smedt, H.
    Parys, J. B.
    Leybaert, L.
    Bultynck, G.
    CELL DEATH AND DIFFERENTIATION, 2012, 19 (02): : 295 - 309
  • [49] Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl
    G Monaco
    E Decrock
    H Akl
    R Ponsaerts
    T Vervliet
    T Luyten
    M De Maeyer
    L Missiaen
    C W Distelhorst
    H De Smedt
    J B Parys
    L Leybaert
    G Bultynck
    Cell Death & Differentiation, 2012, 19 : 295 - 309
  • [50] Therapeutic potential of the novel Bcl-2/Bcl-XL dual inhibitor, APG1252, alone or in combination against non-small cell lung cancer
    Qian, Luxi
    Vallega, Karin A.
    Yao, Weilong
    Wang, Dongsheng
    Zhai, Yifan
    He, Xia
    Sun, Shi-Yong
    MOLECULAR CARCINOGENESIS, 2022, 61 (11) : 1031 - 1042
12345